Position in NVS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$278,004
-$108,306 QoQ
Shares Held
1,820
-35.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elyxium Wealth, LLC holds $29,523,474 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
48,286 | $12,150,687 | |
| 2 | LLY |
ELI LILLY & Co
|
6,087 | $7,300,929 | |
| 3 | AMGN |
Amgen Inc
|
14,252 | $5,160,932 | |
| 4 | JNJ |
Johnson & Johnson
|
10,749 | $2,729,921 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,919 | $1,017,591 | |
| 6 | PFE |
Pfizer Inc
|
20,580 | $495,565 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,502 | $442,441 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,912 | $225,408 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $278,004 | 1,820 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $386,310 | 2,802 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $328,549 | 2,562 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||